Certara

CERT Small Cap

Healthcare · Health Information Services

Updated: Apr 5, 2026, 17:43 UTC

$5.41

-1.64% today

52W: $5.24 – $15.38

52W Low: $5.24 Position: 1.7% 52W High: $15.38

🔗 Compare Brokers

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

10.85x

Forward Price/Earnings

P/S Ratio

2.06x

Price-to-Sales

EV/EBITDA

9.95x

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$861.7M

Market Capitalization

Revenue Growth

3.3%

YoY Revenue Growth

Profit Margin

-0.38%

Net profit margin

ROE

-0.15%

Return on Equity

Beta

1.62

Market sensitivity

Short Interest

19.92%

% of float sold short

Avg. Volume

3,402,986

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

11 analysts

Avg. Price Target

$8.99

+66.11% upside

Target Range

$6.35 – $11.00

About the Company

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and func

Sector: Healthcare Industry: Health Information Services Country: United States Employees: 1,515 Exchange: NMS